Drug-induced alterations in Mg2+ homoeostasis. - Wikidata - awgldk - TriplyDB

Drug-induced alterations in Mg2+ homoeostasis.

Drug-induced alterations in Mg2+ homoeostasis.

http://www.wikidata.org/entity/Q37992700

about

Proton-pump inhibitor-induced hypomagnesemia: Current research and proposed mechanisms Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?The relationship between hypomagnesemia, metformin therapy and cardiovascular disease complicating type 2 diabetes: the Fremantle Diabetes Study Renal control of calcium, phosphate, and magnesium homeostasis 'Lemonade Legs': Why do Some Patients Get Profound Hypomagnesaemia on Proton-Pump Inhibitors?Intravenous infusion of magnesium chloride improves epicenter blood flow during the acute stage of contusive spinal cord injury in rats.Identification of SLC41A3 as a novel player in magnesium homeostasis.IGF-1, the cross road of the nutritional, inflammatory and hormonal pathways to frailty The Interplay between Magnesium and Testosterone in Modulating Physical Function in Men.Addressing potential role of magnesium dyshomeostasis to improve treatment efficacy for epilepsy: A reexamination of the literature.Perspective: The Case for an Evidence-Based Reference Interval for Serum Magnesium: The Time Has Come.Omeprazole enhances the colonic expression of the Mg(2+) transporter TRPM6.Elucidation of the distal convoluted tubule transcriptome identifies new candidate genes involved in renal Mg(2+) handling.Recurrent FXYD2 p.Gly41Arg mutation in patients with isolated dominant hypomagnesaemia.Longitudinal Study of the Role of Epidermal Growth Factor on the Fractional Excretion of Magnesium in Children: Effect of Calcineurin Inhibitors.

P2860

Q26765064-346A83E6-2CF4-454D-B06F-8984D46884F6 Q30620638-AD270D55-7FA7-453C-AEBF-0BE12DD64D93 Q31138001-0A162991-AA30-433C-A14D-FADCD2922EAE Q34442093-D531A23A-E6BB-4865-A01B-F2EDEBB460CC Q35777866-2BAD6E5B-F68A-4111-8BAA-BAF959B31B5E Q36862969-EFA6421A-47C3-4CE6-AA31-DD4262F8FB71 Q37044436-DF9D29B3-0044-4098-BE54-A12081789B07 Q37286765-25B3DCC7-09ED-43DE-A809-27CD73FEAE5C Q37645065-33E4D5B7-A967-43C0-8BBB-83A0DF42FEFF Q38574978-E5FA4EEE-C8F2-43B0-94E4-E8FD52E93DD9 Q38989905-4C1796AF-99E1-442C-A594-402052AA3E8D Q43457054-3283AE6C-ADFD-4F37-AF6C-70BA35BFF9DB Q50471741-1F927910-8622-4214-9047-7FE884DD1171 Q55058934-0C0447F6-4E81-472F-A7AC-00E4C7B9E756 Q55515010-075701C9-83E2-4154-A264-7355336EC838

P2860

Drug-induced alterations in Mg2+ homoeostasis.

http://www.wikidata.org/entity/Q37992700

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Drug-induced alterations in Mg2+ homoeostasis.

@en

Drug-induced alterations in Mg2+ homoeostasis.

@nl

type

label

Drug-induced alterations in Mg2+ homoeostasis.

@en

Drug-induced alterations in Mg2+ homoeostasis.

@nl

prefLabel

Drug-induced alterations in Mg2+ homoeostasis.

@en

Drug-induced alterations in Mg2+ homoeostasis.

@nl

P1433

Q37992700-FD797632-1EF5-40C7-85B9-037AFABEA984

P1476

Q37992700-72A3F111-50CD-4BA7-B0C7-41615030899B

P2093

Q37992700-0337C9CF-7563-452C-84A9-9DAF6B95CCF7

Q37992700-5B670F71-2220-420E-96F0-072AE89541BD

Q37992700-66B23220-0C84-45AC-85A9-BE465D1A49A2

Q37992700-A14FD16A-C9BF-47E6-B1AF-9E4EA55F1AD9

P2860

Q37992700-017F5112-57B7-4868-8142-F64B1E9A4FAB

Q37992700-16876FAB-EADE-47A0-9D0F-46FE645BE11F

Q37992700-16FA619C-800E-4096-BB87-AEB52E223911

Q37992700-20C2943D-C59A-47EA-A92C-E83C0E38174F

Q37992700-214BBF59-EF98-47F2-A604-D9D9357733CA

Q37992700-239ADD7D-8104-4A7D-BFF9-B09137C45FD4

Q37992700-261B06B4-A14E-44DB-A2B0-98F2BC36A6E7

Q37992700-29310F39-77E5-4744-9402-23DD5ADF9910

Q37992700-298BA4CA-ECAB-4EEB-AAC2-FACA9850DE51

Q37992700-2C35D1B5-D336-4BC0-9A52-48065500A048

P304

Q37992700-962603CB-35F1-4014-B3FE-D1BF61565891

P31

Q37992700-7B42C79B-7E44-4B9A-9947-38053A90F21A

P356

Q37992700-62002F2B-5D47-4725-A63B-5BF2315FBA1D

P407

Q37992700-88887222-C86B-4619-8A4C-A5450C56C4EF

P433

Q37992700-AF1C6927-9C7D-4F71-A6B9-9EB3448F66A3

P478

Q37992700-24455D65-9321-43C7-8692-A55B88BBF03D

P577

Q37992700-76175F8A-FBA7-4DE7-BAB0-CD5E1FB6B8E5

P698

Q37992700-0134A0CF-0EF9-4CD7-86C3-A3B8AC72AC59

P356

P1433

Clinical Science

P1476

Drug-induced alterations in Mg2+ homoeostasis.

@en

P2093

Anke L Lameris

http://www.w3.org/2001/XMLSchema#string

Joost G J Hoenderop

http://www.w3.org/2001/XMLSchema#string

Leo A Monnens

http://www.w3.org/2001/XMLSchema#string

René J Bindels

http://www.w3.org/2001/XMLSchema#string

P2860

CNNM2, encoding a basolateral protein required for renal Mg2+ handling, is mutated in dominant hypomagnesemia

A missense mutation in the Kv1.1 voltage-gated potassium channel-encoding gene KCNA1 is linked to human autosomal dominant hypomagnesemia

Hereditary isolated renal magnesium loss maps to chromosome 11q23.

Disruption of TRPM6/TRPM7 complex formation by a mutation in the TRPM6 gene causes hypomagnesemia with secondary hypocalcemia

Novel TRPM6 mutations in 21 families with primary hypomagnesemia and secondary hypocalcemia

Symptomatic hypocalcemia and hypomagnesemia with renal magnesium wasting associated with pentamidine therapy in a patient with AIDS

Hypomagnesaemic tetany associated with prolonged treatment with aminoglycosides

Decrease in transient receptor potential melastatin 6 mRNA stability caused by rapamycin in renal tubular epithelial cells

Aminoglycosides induce acute cell signaling and chronic cell death in renal cells that express the calcium-sensing receptor.

Cisplatin and hypomagnesemia.

P304

1-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1042/CS20120045

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22409531

http://www.w3.org/2001/XMLSchema#string